Heart failure presents a growing public health problem both in Estonia and across Europe. At the same time, ...

At its core, GPT-Rosalind is the first in a new series of models optimized for scientific workflows. While previous ...

As we have moved to interconnected systems, digital artifacts wind up in the cloud, on the Internet, and in AI models,” said ...

GPT-Rosalind is OpenAI's first domain-specific model, built for drug discovery and life sciences—and it's not for everyone.

AI thrives on data but feeding it the right data is harder than it seems. As enterprises scale their AI initiatives, they ...

OpenAI is framing GPT-Rosalind as a tool to compress the timeline from scientific idea to clinical evidence. The company ...

That’s according to recent reports from SentinelOne and Fortinet. Meanwhile, AI speeds up attacks, automating exploits and creating deepfakes that hit faster than ever. You deal with prompt injection ...

By Juby Babu April 16 - OpenAI on Thursday introduced an artificial intelligence model touting increased biology knowledge ...

Getting a drug from initial target discovery to U.S. regulatory approval takes between 10 and 15 years on average. Most of ...

The GPT-Rosalind model is designed to accelerate biological research and drug discovery. View on euronews ...

At MWC 2026, Huawei released its AIDP. This platform integrates a knowledge base, KV cache acceleration, and a memory bank, and uses the Unified Cache Manager (UCM) to manage and schedule inference ...

OpenAI have announced the early release of its new AI-powered life sciences application GPT-Rosalind to specific life science groups.